Literature DB >> 1672166

Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.

B G Bonde1, M Sharif, M L Privalsky.   

Abstract

The avian erythroblastosis virus v-erbA oncogene is imprecisely derived from a cellular gene (c-erbA) encoding a thyroid hormone receptor: the v-erbA protein has sustained both small terminal deletions and internal amino acid sequence changes relative to c-erbA. We report here that one of these missense differences between v- and c-erbA proteins, located in a zinc finger DNA binding domain, has dramatic effects on the biological activities of the encoded protein. Back mutation of the viral coding sequence to resemble c-erbA at this site severely impairs erythroid transformation and produces subtle changes in DNA binding by the encoded protein, suggesting that differences in DNA binding by the viral and cellular proteins may be involved in the activation of v-erbA as an oncogene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672166      PMCID: PMC240051     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Evidence for the multiple oncogenic potential of cloned leukemia virus: in vitro and in vitro studies with avian erythroblastosis virus.

Authors:  T Graf; B Royer-Pokora; G E Schubert; H Beug
Journal:  Virology       Date:  1976-06       Impact factor: 3.616

2.  A tail of two src's: mutatis mutandis.

Authors:  T Hunter
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  v-src mutations outside the carboxyl-coding region are not sufficient to fully activate transformation by pp60c-src in NIH 3T3 cells.

Authors:  S Reddy; P Yaciuk; T E Kmiecik; P M Coussens; D Shalloway
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

4.  Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies.

Authors:  Z D Horowitz; C R Yang; B M Forman; J Casanova; H H Samuels
Journal:  Mol Endocrinol       Date:  1989-01

5.  v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene.

Authors:  M Zenke; P Kahn; C Disela; B Vennström; A Leutz; K Keegan; M J Hayman; H R Choi; N Yew; J D Engel
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

6.  Structural domains of the avian erythroblastosis virus erbB protein required for fibroblast transformation: dissection by in-frame insertional mutagenesis.

Authors:  M Ng; M L Privalsky
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  Retinoic acid and thyroid hormone induce gene expression through a common responsive element.

Authors:  K Umesono; V Giguere; C K Glass; M G Rosenfeld; R M Evans
Journal:  Nature       Date:  1988-11-17       Impact factor: 49.962

8.  A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase.

Authors:  S K Nordeen; P P Green; D M Fowlkes
Journal:  DNA       Date:  1987-04

9.  Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation.

Authors:  V W Wilkerson; D L Bryant; J T Parsons
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  The viral erbA oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast.

Authors:  M L Privalsky; M Sharif; K R Yamamoto
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

View more
  9 in total

1.  The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors.

Authors:  O Wessely; E M Deiner; H Beug; M von Lindern
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

2.  The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.

Authors:  H W Chen; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

3.  Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.

Authors:  A Baniahmad; S Y Tsai; B W O'Malley; M J Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).

Authors:  F Saatcioglu; P Bartunek; T Deng; M Zenke; M Karin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain.

Authors:  H Chen; Z Smit-McBride; S Lewis; M Sharif; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

6.  Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action.

Authors:  Corinne Bresson; Celine Keime; Claudine Faure; Yann Letrillard; Maud Barbado; Sandra Sanfilippo; Najate Benhra; Olivier Gandrillon; Sandrine Gonin-Giraud
Journal:  BMC Genomics       Date:  2007-10-26       Impact factor: 3.969

7.  Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.

Authors:  S Fuerstenberg; I Leitner; C Schroeder; H Schwarz; B Vennström; H Beug
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

8.  Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.

Authors:  C Barlow; B Meister; M Lardelli; U Lendahl; B Vennström
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

9.  Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.

Authors:  D Barettino; T H Bugge; P Bartunek; M D Vivanco Ruiz; V Sonntag-Buck; H Beug; M Zenke; H G Stunnenberg
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.